SlideShare a Scribd company logo
CPH© - All Rights Reserved 2011
Proper Prescribing of
Controlled Prescription Drugs©
Center for Professional Health©
Module 1:
Overview: The Controlled Prescription Drug
Epidemic, Physician Misprescribing and the Roles of
the DEA and Medical Board
CPH© - All Rights Reserved 2011
Target Audience
This learning module is designed for all physicians and
healthcare providers who prescribe controlled prescription
drugs.
CPH© - All Rights Reserved 2011
Objectives
Participants completing this module will be able to:
1. Discuss the controlled prescription drugs (CPD)
epidemic.
2. Define misprescribing of CPD.
3. Compare and contrast the role of the medical
board and the Drug Enforcement Administration
(DEA).
4. Determine one’s risk for misprescribing.
CPH© - All Rights Reserved 2011
References and Resources
All data, references and resources provided in these
modules are linked to main source or reference. You can
learn more about any report by clicking the link. Links
are displayed by hyperlink, picture/logo, or web-page
link.
Examples:
• Picture link: (click on picture)
• Web-page link:
– www.mc.vanderbilt.edu/cph
• Hyperlink:
– Center for Professional Health
CPH© - All Rights Reserved 2011
Rights & Responsibilities
Our job is to provide you with important and valuable
information to improve your understanding of prescribing
controlled drugs and prepare you for challenges you may
face in your practice.
We are committed to providing educational programs for
all students, trainees and all healthcare providers.
Please do not copy or reproduce this information without
written approval from the Center for Professional Health
(CPH). To request permission to reproduce or use any
part of The Proper Prescribing of Controlled Prescription
Drugs© or any other CPH program or materials, please
contact us at cph@vanderbilt.edu. Thank you.
CPH© - All Rights Reserved 2011
Introduction
“No one ever told me the
rules. This was never
taught in medical school.”
~ CPH participant
CPH© - All Rights Reserved 2011
Introduction
Welcome! This course could save
your career! Many of us don’t think
about the consequences of
misprescribing, but we should.
Over >900 physicians and other
healthcare providers from 40 states,
Canada and Europe have attended
our proper prescribing course at the
Center for Professional Health at
Vanderbilt between 1998 and 2014
and many others have gone to similar
programs around the country.
CPH© - All Rights Reserved 2011
Introduction
Many of these physicians face years of career
challenges due to probation, suspension or revocation of
their medical license or DEA registration. All of these can
result in significant fines (into the six figure range), loss
of patients, community respect, faculty appointments,
and sometimes, in the case of revocation, loss of career.
The information contained within these modules will help
arm you with valuable information to prevent
misprescribing and guide you in ways that may protect
you if you are investigated by the state medical board or
the DEA.
CPH© - All Rights Reserved 2011
Introduction
Can you answer these questions:
1. What are the criteria for misprescribing?
2. What are the potential consequences for a physician who
is sanctioned for misprescribing?
3. Would you know what to do if you are sanctioned for
misprescribing?
4. Have you kept abreast of the latest information on the use
of opioids for chronic pain?
5. What are the latest guidelines regarding screening for
substance use in patients requesting controlled
prescription drugs?
6. Can you identify and manage a patient who misuses
controlled substances?
CPH© - All Rights Reserved 2011
Introduction
If you answered NO for any of these
three questions, then this module is
for you!
We feel it is far better to gain new
knowledge than to experience being
sanctioned by the medical board.
This is the first module within the
series. Complete as many modules
as you wish or only those most
applicable at this time.
Revocation
Sanction
Intervention
Prevention
CPH© - All Rights Reserved 2011
Instructions
Complete the module in order. If you need to return to a
section, use the icon to return to the table of
contents. This icon is located in the top right hand corner
of each page.
Click on the title in the table of contents to go directly to
that section in the module.
CPH© - All Rights Reserved 2011
Table of Contents
Table of Contents
Importance
The CPD Epidemic
Misprescribing CPDs
Role of the State Medical Board
Role of the DEA
Summary
CPH© - All Rights Reserved 2011
Part 1:
CPH© - All Rights Reserved 2011
Importance
Did you know that writing one
prescription for a controlled
substance can cost you a lot of time
and money, result in restrictions being
placed on your prescribing license,
your license to practice medicine, and
possibly cost you your career?
The sad truth is that it can happen. Many physicians
have already lost prescribing privileges, medical
licenses, jobs, respect, and careers over misprescribing
practices.
CPH© - All Rights Reserved 2011
Importance
The media will play up the cases of popular individuals
who lose their lives due to abuse of controlled
prescription drugs (CPD), but what is not always
publicized is the story of the everyday physician who lost
his/her license to practice because they misprescribed
and weren’t even aware of it.
CPH© - All Rights Reserved 2011
Importance
All healthcare providers who prescribe controlled
substances should be well aware that they will be held
accountable for their prescribing practices; thus every
prescribing physician should follow the published
guidelines.
CPH© - All Rights Reserved 2011
Importance
How familiar are you with the following prescribing
guidelines?
 The Medical Practice Act
 The Controlled Substances Act
 Drug Enforcement Administration Practitioner’s Manual
 The Federation’s prescribing guidelines
 Your state medical board’s prescribing requirements
CPH© - All Rights Reserved 2011
Importance
Our experience with training hundreds of physicians
teaches us that most have had less than 1-2 hours of
training on prescribing practices and/or drug diversion
during medical school or residency training.
How much training did you receive on proper prescribing
guidelines? Select only one answer.
a) None
b) 1-2 hrs
c) 3-4 hrs
d) >5 hrs
CPH© - All Rights Reserved 2011
Part 2:
CPH© - All Rights Reserved 2011
The CPD Epidemic
Substance abuse, including controlled prescription drugs
(CPD), is the nation's number one health problem
affecting millions of individuals according to The Robert
Wood Johnson Foundation.
Illicit drug use, including controlled prescription drugs
(pain relievers, stimulants, sedatives, and tranquilizers),
marijuana, cocaine, heroin, hallucinogens, and inhalants
cost the U.S. economy over $193 billion dollars in 2007;
more than either diabetes or smoking alone. (One DCP
update vol2;iss5, June 2011)
CPH© - All Rights Reserved 2011
The CPD Epidemic
"There are more deaths,
illnesses and disabilities from
substance abuse than from
any other preventable health
condition. Of the more than 2
million deaths each year in the
United States, approximately
one in four is attributed to
alcohol, tobacco and illicit drug
use."
CPH© - All Rights Reserved 2011
The CPD Epidemic
“According to the 2012 National Survey on Drug Use and
Health, almost twice as many Americans (6.8 million)
currently abuse pharmaceutical controlled substances
than those using cocaine, hallucinogens, heroin and
inhalants combined.”
“Nearly 110 Americans die every day from drug-related
overdoses, and about half of those overdoses are
related to opioids, a class of drug that includes
prescription painkillers and heroin.”
CPH© - All Rights Reserved 2011
The CPD Epidemic
“More than two-thirds of people who misuse prescription
painkillers for the first time report obtaining the drugs
from friends or relatives, including from a home medicine
cabinet.”
“In July, the Office of National Drug Control Policy
(ONDCP) released the 2014 National Drug Control
Strategy, which is a “shift away from a law enforcement
emphasis and towards a public health and prevention
approach to drug-related harm,” according to Davis.”
CPH© - All Rights Reserved 2011
The CPD Epidemic
“He added that the Strategy emphasizes evidence-based
efforts such as increased access to treatment, criminal
justice reform and access to naloxone for opioid
overdose reversal.”
To read more on this report click the RWJ link.
CPH© - All Rights Reserved 2011
The CPD Epidemic
“Under the Affordable Care Act, most health insurance
plans must cover mental health and substance use
disorder (SUD) services. The ACA has also created
improved access for SUD services by extending a
federal law that requires SUD benefits be provided at the
same reimbursement rate as medical and surgical
benefits.” – RWJ Foundation web page
To read more on this report click the RWJ link.
CPH© - All Rights Reserved 2011
The CPD Epidemic
An estimated 22.6 million Americans (>12 years of age)
admitted to using illicit drugs within the past month and
this equates to 8.9% for this population and up to 22%
for those 18-22 years of age. (SAMSHA)
The rate of controlled prescription drug abuse has
increased 94% in the past decade (1992 to 2003). Rates
have nearly tripled in the teenage population (12 -17
years old) - an increase of 212% compared to 81%
increase in the adult population. (Bollinger)
CPH© - All Rights Reserved 2011
The CPD Epidemic
Rate of controlled prescription drug (CPD) abuse –
nearly doubled from 7.8 million to 15.1 million in the past
decade (1992 to 2003)
• Adults: Use in adults (>18 years) is up by 81%
• Teens: Rate has nearly tripled for teen population (age
12 -17):
– abusing CPD more than adults
– rate estimated at 212%
CPH© - All Rights Reserved 2011
The CPD Epidemic
In 2010, of the three million new users of illicit drugs for
youth aged 12 and older, 62% used marijuana and 26%
use CPD. (SAMSHA)
Controlled prescription drugs (opioids, stimulants and
benzodiazepines) rank number four on the list of most
abused substances falling just under marijuana, alcohol
and tobacco. (Bollinger)
CPH© - All Rights Reserved 2011
The CPD Epidemic
Americans make up 4.6% of world’s population but
use…
– 66% of world’s illicit drugs
– 80% of global opioid supply
– 99% of global hydrocodone supply
2006 National Survey on Drug Abuse and Health, SAMHSA
CPH© - All Rights Reserved 2011
The CPD Epidemic
“Drug overdose death rates in the United States have
more than tripled since 1990 and have never been
higher. In 2008, more than 36,000 people died from drug
overdoses, and most of these deaths were caused by
prescription drugs.4”
• Drug OD from CPD has tripled in two decades (CDC)
• 100 people die from OD every day in US (CDC)
• Men are more likely to die of opioid overdoses (>10,000
deaths in 2010) (CDC)
• Rate of opioid OD for women is increasing (CDC)
CPH© - All Rights Reserved 2011
The CPD Epidemic
More “new users” tried opioids for non-medical reasons
in the past year than any other illicit drug
According to the CDC:
– Opioid prescription painkillers cause more drug overdose
deaths than cocaine and heroin combined
– Increased ER visits
– Increased accidental deaths
– Health care costs = millions of dollars annually
DEA Practitioners Manual 2006 ed.; Manchikanti L, et al. 2005; Substance Abuse 2001; Bollinger LC 2005. 2006 National Survey on Drug
Abuse and Health, SAMHSA
CPH© - All Rights Reserved 2011
The CPD Epidemic
The CPD epidemic is real and affects many individuals.
The problem with the misuse and illicit use of CPD is the
excess burden on the health care system, the individual,
family members and the community as a whole.
Physicians play two important roles in this problem:
1) Physicians are the main source of CPD.
2) Physicians do not always identify and intervene when
misuse and dependence develops.
CPH© - All Rights Reserved 2011
The CPD Epidemic
Prescription drug diversion is simply the deflection of
prescription drugs from medical sources into the illegal
market.
• Physicians remain the #1 provider of CPD
• Other Sources:
– doctor shopping
– illegal internet pharmacies
– drug theft
– prescription forgery
– illicit prescribing by physicians
U.S. Department of Justice, Drug Enforcement Administration, Prescription Accountability Resource Guide, September
1998, <http://www.deadiversion.usdoj.gov/pubs/program/rx_account/index.html > (5 January 2004).
CPH© - All Rights Reserved 2011
The CPD Epidemic
Source: The Monitoring the Future Study, the University of Michigan
Physician misprescribing accounts for most of the excess CPD available for diversion.
CPH© - All Rights Reserved 2011
The CPD Epidemic
• Up to 43% of physicians DO NOT ask about controlled
prescription drug abuse when taking a patient's health
history.
• Only 19% received any medical school training in
identifying prescription drug diversion.
• Only 40% received training to identify prescription
drug abuse and addiction.
• Many are not trained to effectively handle drug-
seeking patients
Center on Addiction and Substance Abuse (CASA). 2005. Under the Counter: The Diversion and Abuse of Controlled
Prescription Drugs in the US. New York: The National Center on Addiction and Substance Abuse (CASA).
CPH© - All Rights Reserved 2011
The CPD Epidemic
Many are not trained to effectively handle drug-seeking
patients due to…
“Confrontational Phobia” - a term used to describe
physicians’ reluctance to say “no” to a patient, thus
making physicians an “easy target for manipulation.”
~ Bollinger et al. Under the Counter: The Diversion and
Abuse of Controlled Prescription Drugs in the U.S. July 2005
Center on Addiction and Substance Abuse (CASA). 2005. Under the Counter: The Diversion and Abuse of Controlled
Prescription Drugs in the US. New York: The National Center on Addiction and Substance Abuse (CASA).
CPH© - All Rights Reserved 2011
Misprescribing CPD
Once a physician becomes known as an easy target,
substance abusers will find ways to take advantage of
them. Here is a comment from a substance abuser:
CASA Substance Abuser:
“Obviously, doctors don’t like to give you controlled substances
easily but if you’re aggressive and persistent enough…and can talk
a good enough game, I don’t know how they could not give it to you.
I mean they’re in the health field and they’re caring people and
they’re trying to take care of their patients’ individual needs.”
~A 52-year-old drug abusing patient interviewed in the CASA study
Bollinger et al, 2005
CPH© - All Rights Reserved 2011
Misprescribing CPD
If the substance abuser knows this much about
physicians, what do physicians know about substance
abusers?
The evidence supports that most physicians weren’t
trained to identify and manage substance abuse. Most
participants in our courses have never had the training
needed to adequately care for the substance abuser or
identify those who started using a CPD for legitimate
reasons but end up with iatrogenic addictions.
Bollinger et al, 2005
CPH© - All Rights Reserved 2011
Reflection
How much training have you had on identifying and
managing substance abuse?
a) None
b) Some
c) A lot
d) I don’t know
CPH© - All Rights Reserved 2011
Misprescribing CPD
CPH© - All Rights Reserved 2011
Misprescribing CPD
What is the physician’s role in misprescribing?
Am I
prescribing for
a legitimate
medical
problem?
Am I
prescribing the
appropriate
amount for the
condition?
Am I giving
patients full
informed
consent?
Did I screen
appropriately
for use vs
misuse?
CPH© - All Rights Reserved 2011
Misprescribing CPD
The majority of excess CPD available for illicit use or
sharing is due to physicians or other healthcare
providers prescribing more pills than a patient needed. A
total of 309 tons of pills were received in the DEA’s 9th
Prescription Drug Take-Back Day in November 2014.
Other Sources for excess CPD:
• doctor shopping
• illegal internet pharmacies
• drug theft
• prescription forgery
• illicit prescribing by physicians
CPH© - All Rights Reserved 2011
Misprescribing CPD
Definition of Misprescribing: Prescribing CPD in
quantities and frequency inappropriate for the patient’s
complaint or illness … or any example below:
Examples:
– Prescribing large quantities, frequent intervals, or crescendo
pattern of CPD
– Progression to multiple drugs
– Prescribing CPD painkillers for trivial complaints
– Prescribing to a family member(s)
– Prescribing to a known alcoholic or drug addict
– Dispensing CPD without a license
CPH© - All Rights Reserved 2011
Misprescribing CPD
Which doctor is at risk of misprescribing?
Answer
1 2 3 4
CPH© - All Rights Reserved 2011
1.Brown ME, Swiggart WH, Dewey CM, Ghulyan MV. Searching for answers: proper prescribing of controlled prescription drugs. Journal of
Psychoactive Drugs. 2012; 44(22641969):79-85.
2.Wesson, D.R. & Smith, D.E. Prescription drug abuse: Patient, physician and cultural responsibilities. Western Journal of Medicine 1990; 152:
613-616.
Misprescribing CPD
Answer: All physicians who prescribe CPD are at risk of
misprescribing if unfamiliar with how to avoid it.
There are several reasons why physicians misprescribe.
Four identified by the AMA and two later identified by the
Center for Professional Health (CPH) (You can read both articles below by
clicking the hyper link.) The team at CPH also identified one for
advanced nurse practitioners (APRN) and may at times
be applicable for physicians as well. Thus physicians
misprescribe for the following reasons …
CPH© - All Rights Reserved 2011
Misprescribing CPD
1.Brown ME, Swiggart WH, Dewey CM, Ghulyan MV. Searching for answers: proper prescribing of controlled prescription drugs. Journal of
Psychoactive Drugs. 2012; 44(22641969):79-85.
2.Wesson, D.R. & Smith, D.E. Prescription drug abuse: Patient, physician and cultural responsibilities. Western Journal of Medicine 1990; 152:
613-616.
CPH© - All Rights Reserved 2011
Misprescribing CPD
Examples:
1. Dated: A physician is unaware of the latest prescribing
guidelines for managing chronic pain and prescribes CPD
over the recommended levels.
2. Duped: This is probably the most common reason for
misprescribing…the physician fails to detect the deceptive
practices of the patient even thought evidence is clearly
present.
3. Dismayed: The patient with several problems and
complications or side effects to other medications and the
physician fails to investigate due to time limitations and
the need to move on to the next patient.
CPH© - All Rights Reserved 2011
Misprescribing CPD
Examples: (cont.)
4. Dysfunctional: This physician feels stressed and
unsure of how to handle the forceful patient and fails
to say no even when the physician may/may not
know the risk involved.
5. Dishonest: This physician, although rare, will
exchange CPD for sexual favors or money at street
prices for various reasons.
6. Disabled: This physician is also a substance user
and may prescribe higher quantities to share with
patients or self-prescribes or uses a family name to
prescribe CPD but will use it for himself.
CPH© - All Rights Reserved 2011
Misprescribing CPD
Examples: (cont.)
7. Disempowered: This physician is disempowered by
a patient or an APRN is disempowered by a patient
or the supervising physician. Either may prescribe
because they failed to exhibit the appropriate level of
assertiveness within the situation.
CPH© - All Rights Reserved 2011
Reflection
Reflect on your past prescribing practices. Have you
misprescribed? If so, how and for what reason?
Categories of Misprescribing
Dated: Fails to keep current
Disabled: Failed judgment due to impairment
Duped: Fails to detect
Dishonest: Personal or financial gain
Dismayed: Rx as a quick fix due to time
Dysfunctional: Fails to say no
Disempowered: Skewed perception of power
CPH© - All Rights Reserved 2011
Consequences of Misprescribing
The consequences for misprescribing can be significant
and life/career changing. The consequences can vary
greatly from state to state. Both the physician’s medical
license and DEA may be restricted or revoked.
It is critical that you practice under the guidelines of your
state medical board and the federal guidelines of the
DEA. Find your state medical board by clicking on the
link below.
CPH© - All Rights Reserved 2011
Consequences of Misprescribing
The physician may be reported
to the National Practitioner Data
Bank, may lose privileges, be
dropped by insurance carriers,
and lose respect from patients
and colleagues.
When misprescribing crosses
the legal lines of justice, a
physician may be arrested.
CPH© - All Rights Reserved 2011
Consequences of Misprescribing
The financial and personal toll of being sanctioned for
misprescribing is significant. Direct and indirect costs
include:
• Loss of income
• Loss of privileges
• Loss of respect
• Costs for educational programs
• Cost for lawyer fees
• Cost for board fees
• Cost for addiction assessments & treatment
CPH© - All Rights Reserved 2011
Part 3:
CPH© - All Rights Reserved 2011
State Medical Board
Under the Modern Medical Practice Act, the “state
medical board, acting as a governmental agency, to
regulate the practice of medicine, including the licensure
and discipline of physicians, in the jurisdiction.” Each
state’s Act varies in how they award or revoke licenses.
In TN, the state board’s mission is to “safeguard the
health, safety, and welfare” of the public and interpret
the laws, rules, and regulations to determine the
“appropriate standards of practice to ensure the
highest degree of professional conduct.” (TN SBME)
CPH© - All Rights Reserved 2011
State Medical Board
Within each state’s regulations, the board will investigate
all complaints of alleged violations.
The board will hold physicians accountable for their
competency and behavior and will strike a balance
between enforcing accountability and being punitive –
meaning they will discipline licensees who are found
guilty of violations based on evidence from an
investigation.
CPH© - All Rights Reserved 2011
State Medical Board
In most instances, the board will render a judgment
based on behavior, not only on patient outcomes, and
will try to distinguish between human error and
intentional reckless behavior.
The board may require education, coaching, non-
disciplinary counseling, training, and request evidence of
competency if appropriate.
CPH© - All Rights Reserved 2011
State Medical Board
The medical board considers disciplinary/punitive action
for any event/medical error resulting from a practitioner
under the influence (ETOH or drugs), recklessly unsafe
practitioners, and any practitioner who has blatantly
disregarded the standards of practice or has committed
a criminal act.
The medical board will not randomly select physicians to
survey or investigate. All inquiries are complaint driven.
When the board receives a complaint, they will
investigate to determine if there is evidence of a possible
violation.
CPH© - All Rights Reserved 2011
State Medical Board
The board’s course of action generally includes:
1) assign an investigator to make an inquiry
2) send a “notice of complaint” to the doctor where an
explanation may be requested
3) the investigator will either schedule a meeting with
the physician or randomly visit the physician
CPH© - All Rights Reserved 2011
State Medical Board
Board investigators will request records to review. The
board will expect that the physician records the following
for each patient receiving CPD:
1. proper indication for the use of the CPD
2. plans for monitoring the patient while on the CPD
3. the response to using a CPD on follow-up visits
4. a rationale for continuing or modifying therapy.
If there is a clear concern for public safety, the board
may take an immediate action and suspend the doctor’s
license.
CPH© - All Rights Reserved 2011
State Medical Board
Most complaints are resolved as follows:
1) Dismissal - lack of evidence to support the claim
2) Letter of Concern - a letter from the board is generated
expressing concern regarding an action
3) Consent Decree - an agreement is used for concerns such as
an expired license or incomplete CME requirements
4) Agreed Order – a formal disciplinary action in which both sides
agree that the complaint is valid and the doctor agrees to certain
terms and/or conditions.
CPH© - All Rights Reserved 2011
State Medical Board
List of actions a board can take:
1. Revocation of the medical license
2. Suspension of the medical license
3. Probation
4. Stipulations, limitations, restrictions, probation, and
conditions relating to practice
5. Censure (including specific redress, if appropriate)
6. Reprimand
7. Chastisement, letters of concern and advisory letters
CPH© - All Rights Reserved 2011
State Medical Board
8. Monetary redress to another party
9. A period of free public or charity
service, either medical or non-
medical
10.Satisfactory completion of an
educational, training and/or
treatment program(s), or
professional developmental plan
11.Levy fine
12.Payment of administrative and
disciplinary costs
CPH© - All Rights Reserved 2011
State Medical Board
If appropriate, the board will proceed with a Hearing - a
formal trial-like procedure where the case is presented to
the medical board panel. In this process, the physician
will take part in a pre-hearing conference (a conference
between the doctor and the investigator including
attorneys to discuss the case) followed by the hearing.
The board will vote on any decisions in open session
and determine a proposed decision. The decision can
be appealed to the Circuit Court within 30 days.
CPH© - All Rights Reserved 2011
State Medical Board
National Practitioners Data Bank: Final actions are
reported to the Data Bank newsletter and web site.
All costs plus penalties are assessed to the physician
and can be excessive especially if the physician retains
a lawyer on his/her behalf.
CPH© - All Rights Reserved 2011
State Medical Board
If a physician receives notice from their board of a
complaint, they should consider seeking guidance from
their state’s physician health program (PHP).
Most states have a PHP and can provide insight into the
process and make suggestions on compliance and
training options. Some will suggest proactive
assessments, training and education. Common PHP and
board suggestions/requirements include training courses
for improving documentation and proper prescribing
such as the CME courses at CPH.
CPH© - All Rights Reserved 2011
Part 4:
CPH© - All Rights Reserved 2011
Drug Enforcement Administration
The mission of the DEA is to enforce the controlled
substances laws and regulations of the United States
and to recommend and support non-enforcement
programs aimed at reducing the availability of illicit
controlled substances.
The DEA was created by President Richard Nixon
through an Executive Order in July 1973 in order to
establish a single unified command to combat "an all-out
global war on the drug menace." Through the Controlled
Substances Act (CSA) of 1970, he assigned legal
authority for the regulation of controlled substances (illicit
and licit).
CPH© - All Rights Reserved 2011
Controlled Substances Act (CSA)
– Monitors:
1. Diversion to illicit use in:
– Self
– Others
2. Maintenance of addictions
3. Iatrogenic addictions
– Defined five (5) schedules
– All prescribers must be registered
CPH© - All Rights Reserved 2011
DEA
The DEA has two major responsibilities:
1. Diversion: The prevention, detection, and investigation of
the diversion of controlled substances from legitimate
channels
2. Adequate Supplies: Ensuring that adequate supplies are
available to meet legitimate domestic medical, scientific, and
industrial needs (production to dispensing)
CPH© - All Rights Reserved 2011
DEA
DEA registration can be suspended or revoked by the
Attorney General upon a finding that the registrant:
– Falsified an application
– Has been convicted of a felony
– Had state license/registration suspended, revoked, or denied
by competent State authority
– Has committed acts that would render registration
inconsistent with the public interest
– Has been excluded (or directed to be excluded) from
participation in a program pursuant to section 1320a-7(a) of
title 42. (improperly filed claims) – this is essentially Medicare
fraud.
CPH© - All Rights Reserved 2011
DEA
The DEA developed and published the Practitioner’s
Manual: An Informational Outline of the Controlled
Substances Act 2006 Edition. It is available on their web
page. The manual provides an overview and practice
guidelines for physicians, physician assistants, advanced
nurse practitioners, and pharmacists.
The DEA remains committed to the 2001 Balanced
Policy of promoting pain relief & preventing abuse of
pain medications. If you have not read the manual, this is
a must read for those prescribing controlled substances.
CPH© - All Rights Reserved 2011
DEA - Questions
1. What constitutes Schedule I or other schedule assignments for
drugs?
2. Identify the schedule for each of the following:
marijuana; morphine; heroin; codeine; LSD; opium; amphetamine;
cocaine
3. How often do you renew your DEA registration and what
happens if you move?
4. Which schedules can be refilled?
5. Can Schedule II prescriptions be faxed?
6. What do the numbers and letters in a DEA number stand for?
How is it different from the NPI number?
7. Can you “detox” a controlled substance user (using methadone)
under your current DEA registration?
DEA Practitioner’s Manual 2006; pg. 5-6 & 9-11 & 21-22 & 23
CPH© - All Rights Reserved 2011
DEA
If you are unsure of any of the answers to the above
questions, please continue reading module 2: The
Proper Prescribing of Controlled Prescription Drugs.
Module 2 combines the guidelines from the Practitioner’s
Manual with a reasonable approach to prescribing
practices based on the standard office practices using
the SOAP format.
CPH© - All Rights Reserved 2011
Summary
Having completed this module you should be able to:
1. Discuss the CPD epidemic.
2. Define misprescribing of CPD.
3. Compare and contrast the role of the medical board
and the DEA.
4. Identified your own risk for misprescribing.
So the question remains, “Are you at risk for
misprescribing?” Continue learning in Module 2 to
determine other risks for misprescribing and some tips to
avoid misprescribing.
CPH© - All Rights Reserved 2011
The Center for Professional Health
Contact us at:
Center for Professional Health
1107 Oxford House
Vanderbilt University Medical Center
Nashville, TN. 37232-4300
(615) 936-0678 (phone)
(615) 936-0676 (fax)
cph@vanderbilt.edu

More Related Content

What's hot

Tips to jumpstart your telemedicine program for addiction
Tips to jumpstart your telemedicine program for addictionTips to jumpstart your telemedicine program for addiction
Tips to jumpstart your telemedicine program for addiction
VSee
 
Case study - Surgery Partners
Case study - Surgery PartnersCase study - Surgery Partners
Case study - Surgery Partners
Dave Chase
 
US Goverment Accountability Office Telehealth report
US Goverment Accountability Office Telehealth reportUS Goverment Accountability Office Telehealth report
US Goverment Accountability Office Telehealth report
VSee
 
Scott Haas USI Alternative Reimbursement Case Study Dropping Medical Spend ov...
Scott Haas USI Alternative Reimbursement Case Study Dropping Medical Spend ov...Scott Haas USI Alternative Reimbursement Case Study Dropping Medical Spend ov...
Scott Haas USI Alternative Reimbursement Case Study Dropping Medical Spend ov...
Dave Chase
 
Me hi hie-landscape-webinar-2014-june
Me hi hie-landscape-webinar-2014-juneMe hi hie-landscape-webinar-2014-june
Me hi hie-landscape-webinar-2014-june
MassEHealth
 
Drug Access Navigation - An Insider's Perspective
Drug Access Navigation - An Insider's PerspectiveDrug Access Navigation - An Insider's Perspective
Drug Access Navigation - An Insider's Perspective
Canadian Cancer Survivor Network
 
Rx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptageRx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptage
OPUNITE
 
Novel treatment options for acute hf a multidisciplinary approach (printer f...
Novel treatment options for acute hf  a multidisciplinary approach (printer f...Novel treatment options for acute hf  a multidisciplinary approach (printer f...
Novel treatment options for acute hf a multidisciplinary approach (printer f...
drucsamal
 
New healthreport 2012
New healthreport 2012New healthreport 2012
New healthreport 2012
Quintiles
 
Behavioral Health Industry Insights - 2016
Behavioral Health Industry Insights - 2016Behavioral Health Industry Insights - 2016
Behavioral Health Industry Insights - 2016
Duff & Phelps
 
Four Effective Opioid Interventions for Healthcare Leaders
Four Effective Opioid Interventions for Healthcare LeadersFour Effective Opioid Interventions for Healthcare Leaders
Four Effective Opioid Interventions for Healthcare Leaders
Health Catalyst
 
Improving statin adherence through interactive voice technology & barrier bre...
Improving statin adherence through interactive voice technology & barrier bre...Improving statin adherence through interactive voice technology & barrier bre...
Improving statin adherence through interactive voice technology & barrier bre...
George Van Antwerp
 
Dr Rachel David
Dr Rachel DavidDr Rachel David
Dr Rachel David
Informa Australia
 
An ACO Case Study: Quality Improvement in Healthcare
An ACO Case Study: Quality Improvement in HealthcareAn ACO Case Study: Quality Improvement in Healthcare
An ACO Case Study: Quality Improvement in Healthcare
Health Catalyst
 
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
OPUNITE
 
Are You Ready for EPCS? Becoming mandatory before you know it.
Are You Ready for EPCS?  Becoming mandatory before you know it.Are You Ready for EPCS?  Becoming mandatory before you know it.
Are You Ready for EPCS? Becoming mandatory before you know it.
David Lovelace, CPHIMS, MHSA
 
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
Forward360 LLC
 
Personal Health Management
Personal Health ManagementPersonal Health Management
Personal Health Management
PwC
 
Physician Leadership in Medicine's New Age
Physician Leadership in Medicine's New AgePhysician Leadership in Medicine's New Age
Physician Leadership in Medicine's New Age
flasco_org
 
PYA Monitors Topics on Healthcare Radar at AlaHA
PYA Monitors Topics on Healthcare Radar at AlaHAPYA Monitors Topics on Healthcare Radar at AlaHA
PYA Monitors Topics on Healthcare Radar at AlaHA
PYA, P.C.
 

What's hot (20)

Tips to jumpstart your telemedicine program for addiction
Tips to jumpstart your telemedicine program for addictionTips to jumpstart your telemedicine program for addiction
Tips to jumpstart your telemedicine program for addiction
 
Case study - Surgery Partners
Case study - Surgery PartnersCase study - Surgery Partners
Case study - Surgery Partners
 
US Goverment Accountability Office Telehealth report
US Goverment Accountability Office Telehealth reportUS Goverment Accountability Office Telehealth report
US Goverment Accountability Office Telehealth report
 
Scott Haas USI Alternative Reimbursement Case Study Dropping Medical Spend ov...
Scott Haas USI Alternative Reimbursement Case Study Dropping Medical Spend ov...Scott Haas USI Alternative Reimbursement Case Study Dropping Medical Spend ov...
Scott Haas USI Alternative Reimbursement Case Study Dropping Medical Spend ov...
 
Me hi hie-landscape-webinar-2014-june
Me hi hie-landscape-webinar-2014-juneMe hi hie-landscape-webinar-2014-june
Me hi hie-landscape-webinar-2014-june
 
Drug Access Navigation - An Insider's Perspective
Drug Access Navigation - An Insider's PerspectiveDrug Access Navigation - An Insider's Perspective
Drug Access Navigation - An Insider's Perspective
 
Rx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptageRx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptage
 
Novel treatment options for acute hf a multidisciplinary approach (printer f...
Novel treatment options for acute hf  a multidisciplinary approach (printer f...Novel treatment options for acute hf  a multidisciplinary approach (printer f...
Novel treatment options for acute hf a multidisciplinary approach (printer f...
 
New healthreport 2012
New healthreport 2012New healthreport 2012
New healthreport 2012
 
Behavioral Health Industry Insights - 2016
Behavioral Health Industry Insights - 2016Behavioral Health Industry Insights - 2016
Behavioral Health Industry Insights - 2016
 
Four Effective Opioid Interventions for Healthcare Leaders
Four Effective Opioid Interventions for Healthcare LeadersFour Effective Opioid Interventions for Healthcare Leaders
Four Effective Opioid Interventions for Healthcare Leaders
 
Improving statin adherence through interactive voice technology & barrier bre...
Improving statin adherence through interactive voice technology & barrier bre...Improving statin adherence through interactive voice technology & barrier bre...
Improving statin adherence through interactive voice technology & barrier bre...
 
Dr Rachel David
Dr Rachel DavidDr Rachel David
Dr Rachel David
 
An ACO Case Study: Quality Improvement in Healthcare
An ACO Case Study: Quality Improvement in HealthcareAn ACO Case Study: Quality Improvement in Healthcare
An ACO Case Study: Quality Improvement in Healthcare
 
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
 
Are You Ready for EPCS? Becoming mandatory before you know it.
Are You Ready for EPCS?  Becoming mandatory before you know it.Are You Ready for EPCS?  Becoming mandatory before you know it.
Are You Ready for EPCS? Becoming mandatory before you know it.
 
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
E-Prescribing Controlled Substances: Opportunities and Experiences - May 2014...
 
Personal Health Management
Personal Health ManagementPersonal Health Management
Personal Health Management
 
Physician Leadership in Medicine's New Age
Physician Leadership in Medicine's New AgePhysician Leadership in Medicine's New Age
Physician Leadership in Medicine's New Age
 
PYA Monitors Topics on Healthcare Radar at AlaHA
PYA Monitors Topics on Healthcare Radar at AlaHAPYA Monitors Topics on Healthcare Radar at AlaHA
PYA Monitors Topics on Healthcare Radar at AlaHA
 

Viewers also liked

Rational drug therapy
Rational drug therapyRational drug therapy
Rational drug therapy
Kiran Sharma
 
Prescription of Drugs to Patient
Prescription of Drugs to PatientPrescription of Drugs to Patient
Prescription of Drugs to Patient
Naveen Kumar Sharma
 
Chapter 5 prescriptions
Chapter 5 prescriptionsChapter 5 prescriptions
Chapter 5 prescriptions
rr0006
 
Rational drug prescribing to essential drugs
Rational drug prescribing to essential drugsRational drug prescribing to essential drugs
Rational drug prescribing to essential drugs
sathyanarayanan varadarajan
 
The prescription
The prescriptionThe prescription
The prescription
Mohammad Masum Chowdhury
 
Essential drug list
Essential drug listEssential drug list
Essential drug list
USmile Ï Ṩṃïlệ
 
Prescription
PrescriptionPrescription
Prescription
Oyshe Ahmed
 

Viewers also liked (7)

Rational drug therapy
Rational drug therapyRational drug therapy
Rational drug therapy
 
Prescription of Drugs to Patient
Prescription of Drugs to PatientPrescription of Drugs to Patient
Prescription of Drugs to Patient
 
Chapter 5 prescriptions
Chapter 5 prescriptionsChapter 5 prescriptions
Chapter 5 prescriptions
 
Rational drug prescribing to essential drugs
Rational drug prescribing to essential drugsRational drug prescribing to essential drugs
Rational drug prescribing to essential drugs
 
The prescription
The prescriptionThe prescription
The prescription
 
Essential drug list
Essential drug listEssential drug list
Essential drug list
 
Prescription
PrescriptionPrescription
Prescription
 

Similar to Proper prescribing module1_revised v2

S_brief_I_referral_T-i
S_brief_I_referral_T-iS_brief_I_referral_T-i
S_brief_I_referral_T-i
medicaldump
 
Consumer health: time for a regulatory re-think?
Consumer health: time for a regulatory re-think?Consumer health: time for a regulatory re-think?
Consumer health: time for a regulatory re-think?
The Economist Media Businesses
 
EHR Meaningful Use ONC Policy Commitee June 16 2009
EHR Meaningful Use ONC Policy Commitee June 16 2009EHR Meaningful Use ONC Policy Commitee June 16 2009
EHR Meaningful Use ONC Policy Commitee June 16 2009
Michael Duffy
 
Hit Potential Peg Schible
Hit Potential   Peg SchibleHit Potential   Peg Schible
Hit Potential Peg Schible
pegscheible
 
The Orphan Drug Act
The Orphan Drug ActThe Orphan Drug Act
The Orphan Drug Act
biotechpro
 
EHR Meaningful Use for Medical Practices
EHR Meaningful Use for Medical PracticesEHR Meaningful Use for Medical Practices
EHR Meaningful Use for Medical Practices
Michael Patrick
 
Catasys, Inc. Executive Informational Overview Introduction
Catasys, Inc. Executive Informational Overview IntroductionCatasys, Inc. Executive Informational Overview Introduction
Catasys, Inc. Executive Informational Overview Introduction
Crystal Research Associates
 
eDetailing: A Strategic Analysis Of Implementation And ROI (mini)
eDetailing: A Strategic Analysis Of Implementation And ROI (mini)eDetailing: A Strategic Analysis Of Implementation And ROI (mini)
eDetailing: A Strategic Analysis Of Implementation And ROI (mini)
Eularis
 
10.1007_s11096-016-0258-9
10.1007_s11096-016-0258-910.1007_s11096-016-0258-9
10.1007_s11096-016-0258-9
Lisanne van den Eijkel
 
Blazing New Trails: Shifting the Focus on Alcohol and Drugs
Blazing New Trails: Shifting the Focus on Alcohol and DrugsBlazing New Trails: Shifting the Focus on Alcohol and Drugs
Blazing New Trails: Shifting the Focus on Alcohol and Drugs
nashp
 
Final dissertation
Final dissertationFinal dissertation
Final dissertation
AjeetRai13
 
Quintiles new healthreport_2011
Quintiles new healthreport_2011Quintiles new healthreport_2011
Quintiles new healthreport_2011
Quintiles
 
Moving Opioid Addiction Treatment Into Primary Medical Care
Moving Opioid Addiction Treatment Into Primary Medical CareMoving Opioid Addiction Treatment Into Primary Medical Care
Moving Opioid Addiction Treatment Into Primary Medical Care
Kolmac Outpatient Recovery Centers
 
Healthiest You employer presentation
Healthiest You employer presentationHealthiest You employer presentation
Healthiest You employer presentation
Robin Davis
 
Healthiest You employer presentation
Healthiest You employer presentationHealthiest You employer presentation
Healthiest You employer presentation
Robin Davis
 
Preventing Medication Errors: A $21 Billion Opportunity
Preventing Medication Errors: A $21 Billion OpportunityPreventing Medication Errors: A $21 Billion Opportunity
Preventing Medication Errors: A $21 Billion Opportunity
Health Catalyst
 
SAC360 Chapter 28 health services research
SAC360 Chapter 28 health services researchSAC360 Chapter 28 health services research
SAC360 Chapter 28 health services research
BealCollegeOnline
 
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Canadian Cancer Survivor Network
 
Directed Project
Directed ProjectDirected Project
Directed Project
Krishna Yanamandra
 
Rx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeterRx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeter
OPUNITE
 

Similar to Proper prescribing module1_revised v2 (20)

S_brief_I_referral_T-i
S_brief_I_referral_T-iS_brief_I_referral_T-i
S_brief_I_referral_T-i
 
Consumer health: time for a regulatory re-think?
Consumer health: time for a regulatory re-think?Consumer health: time for a regulatory re-think?
Consumer health: time for a regulatory re-think?
 
EHR Meaningful Use ONC Policy Commitee June 16 2009
EHR Meaningful Use ONC Policy Commitee June 16 2009EHR Meaningful Use ONC Policy Commitee June 16 2009
EHR Meaningful Use ONC Policy Commitee June 16 2009
 
Hit Potential Peg Schible
Hit Potential   Peg SchibleHit Potential   Peg Schible
Hit Potential Peg Schible
 
The Orphan Drug Act
The Orphan Drug ActThe Orphan Drug Act
The Orphan Drug Act
 
EHR Meaningful Use for Medical Practices
EHR Meaningful Use for Medical PracticesEHR Meaningful Use for Medical Practices
EHR Meaningful Use for Medical Practices
 
Catasys, Inc. Executive Informational Overview Introduction
Catasys, Inc. Executive Informational Overview IntroductionCatasys, Inc. Executive Informational Overview Introduction
Catasys, Inc. Executive Informational Overview Introduction
 
eDetailing: A Strategic Analysis Of Implementation And ROI (mini)
eDetailing: A Strategic Analysis Of Implementation And ROI (mini)eDetailing: A Strategic Analysis Of Implementation And ROI (mini)
eDetailing: A Strategic Analysis Of Implementation And ROI (mini)
 
10.1007_s11096-016-0258-9
10.1007_s11096-016-0258-910.1007_s11096-016-0258-9
10.1007_s11096-016-0258-9
 
Blazing New Trails: Shifting the Focus on Alcohol and Drugs
Blazing New Trails: Shifting the Focus on Alcohol and DrugsBlazing New Trails: Shifting the Focus on Alcohol and Drugs
Blazing New Trails: Shifting the Focus on Alcohol and Drugs
 
Final dissertation
Final dissertationFinal dissertation
Final dissertation
 
Quintiles new healthreport_2011
Quintiles new healthreport_2011Quintiles new healthreport_2011
Quintiles new healthreport_2011
 
Moving Opioid Addiction Treatment Into Primary Medical Care
Moving Opioid Addiction Treatment Into Primary Medical CareMoving Opioid Addiction Treatment Into Primary Medical Care
Moving Opioid Addiction Treatment Into Primary Medical Care
 
Healthiest You employer presentation
Healthiest You employer presentationHealthiest You employer presentation
Healthiest You employer presentation
 
Healthiest You employer presentation
Healthiest You employer presentationHealthiest You employer presentation
Healthiest You employer presentation
 
Preventing Medication Errors: A $21 Billion Opportunity
Preventing Medication Errors: A $21 Billion OpportunityPreventing Medication Errors: A $21 Billion Opportunity
Preventing Medication Errors: A $21 Billion Opportunity
 
SAC360 Chapter 28 health services research
SAC360 Chapter 28 health services researchSAC360 Chapter 28 health services research
SAC360 Chapter 28 health services research
 
Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)Pharmacare - Caveat Emptor (Let the Buyer Beware)
Pharmacare - Caveat Emptor (Let the Buyer Beware)
 
Directed Project
Directed ProjectDirected Project
Directed Project
 
Rx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeterRx15 tpp tues_330_1_gavin_2nader_3jeter
Rx15 tpp tues_330_1_gavin_2nader_3jeter
 

More from bahlinnm

Whole body ct adult versus ped centers (iep)
Whole body ct  adult versus ped centers (iep)Whole body ct  adult versus ped centers (iep)
Whole body ct adult versus ped centers (iep)
bahlinnm
 
Jan 2016 iep
Jan 2016 iepJan 2016 iep
Jan 2016 iep
bahlinnm
 
Slide set for on site demo
Slide set for on site demoSlide set for on site demo
Slide set for on site demo
bahlinnm
 
Traumagram winter 2016 final
Traumagram winter 2016 finalTraumagram winter 2016 final
Traumagram winter 2016 final
bahlinnm
 
Traumagram winter 2016 content only
Traumagram winter 2016 content onlyTraumagram winter 2016 content only
Traumagram winter 2016 content only
bahlinnm
 
10 30-15 hh content
10 30-15 hh content10 30-15 hh content
10 30-15 hh content
bahlinnm
 
Worksheet lo educ_assess
Worksheet lo educ_assessWorksheet lo educ_assess
Worksheet lo educ_assess
bahlinnm
 
Assessment instruction module
Assessment instruction moduleAssessment instruction module
Assessment instruction module
bahlinnm
 
Ace ai module 1 slides part 1
Ace ai module 1 slides part 1Ace ai module 1 slides part 1
Ace ai module 1 slides part 1
bahlinnm
 
Ace ai module 1 slides part 2
Ace ai module 1 slides part 2Ace ai module 1 slides part 2
Ace ai module 1 slides part 2
bahlinnm
 

More from bahlinnm (10)

Whole body ct adult versus ped centers (iep)
Whole body ct  adult versus ped centers (iep)Whole body ct  adult versus ped centers (iep)
Whole body ct adult versus ped centers (iep)
 
Jan 2016 iep
Jan 2016 iepJan 2016 iep
Jan 2016 iep
 
Slide set for on site demo
Slide set for on site demoSlide set for on site demo
Slide set for on site demo
 
Traumagram winter 2016 final
Traumagram winter 2016 finalTraumagram winter 2016 final
Traumagram winter 2016 final
 
Traumagram winter 2016 content only
Traumagram winter 2016 content onlyTraumagram winter 2016 content only
Traumagram winter 2016 content only
 
10 30-15 hh content
10 30-15 hh content10 30-15 hh content
10 30-15 hh content
 
Worksheet lo educ_assess
Worksheet lo educ_assessWorksheet lo educ_assess
Worksheet lo educ_assess
 
Assessment instruction module
Assessment instruction moduleAssessment instruction module
Assessment instruction module
 
Ace ai module 1 slides part 1
Ace ai module 1 slides part 1Ace ai module 1 slides part 1
Ace ai module 1 slides part 1
 
Ace ai module 1 slides part 2
Ace ai module 1 slides part 2Ace ai module 1 slides part 2
Ace ai module 1 slides part 2
 

Recently uploaded

Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
Donc Test
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
debosmitaasanyal1
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 

Recently uploaded (20)

Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loopLOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 

Proper prescribing module1_revised v2

  • 1. CPH© - All Rights Reserved 2011 Proper Prescribing of Controlled Prescription Drugs© Center for Professional Health© Module 1: Overview: The Controlled Prescription Drug Epidemic, Physician Misprescribing and the Roles of the DEA and Medical Board
  • 2. CPH© - All Rights Reserved 2011 Target Audience This learning module is designed for all physicians and healthcare providers who prescribe controlled prescription drugs.
  • 3. CPH© - All Rights Reserved 2011 Objectives Participants completing this module will be able to: 1. Discuss the controlled prescription drugs (CPD) epidemic. 2. Define misprescribing of CPD. 3. Compare and contrast the role of the medical board and the Drug Enforcement Administration (DEA). 4. Determine one’s risk for misprescribing.
  • 4. CPH© - All Rights Reserved 2011 References and Resources All data, references and resources provided in these modules are linked to main source or reference. You can learn more about any report by clicking the link. Links are displayed by hyperlink, picture/logo, or web-page link. Examples: • Picture link: (click on picture) • Web-page link: – www.mc.vanderbilt.edu/cph • Hyperlink: – Center for Professional Health
  • 5. CPH© - All Rights Reserved 2011 Rights & Responsibilities Our job is to provide you with important and valuable information to improve your understanding of prescribing controlled drugs and prepare you for challenges you may face in your practice. We are committed to providing educational programs for all students, trainees and all healthcare providers. Please do not copy or reproduce this information without written approval from the Center for Professional Health (CPH). To request permission to reproduce or use any part of The Proper Prescribing of Controlled Prescription Drugs© or any other CPH program or materials, please contact us at cph@vanderbilt.edu. Thank you.
  • 6. CPH© - All Rights Reserved 2011 Introduction “No one ever told me the rules. This was never taught in medical school.” ~ CPH participant
  • 7. CPH© - All Rights Reserved 2011 Introduction Welcome! This course could save your career! Many of us don’t think about the consequences of misprescribing, but we should. Over >900 physicians and other healthcare providers from 40 states, Canada and Europe have attended our proper prescribing course at the Center for Professional Health at Vanderbilt between 1998 and 2014 and many others have gone to similar programs around the country.
  • 8. CPH© - All Rights Reserved 2011 Introduction Many of these physicians face years of career challenges due to probation, suspension or revocation of their medical license or DEA registration. All of these can result in significant fines (into the six figure range), loss of patients, community respect, faculty appointments, and sometimes, in the case of revocation, loss of career. The information contained within these modules will help arm you with valuable information to prevent misprescribing and guide you in ways that may protect you if you are investigated by the state medical board or the DEA.
  • 9. CPH© - All Rights Reserved 2011 Introduction Can you answer these questions: 1. What are the criteria for misprescribing? 2. What are the potential consequences for a physician who is sanctioned for misprescribing? 3. Would you know what to do if you are sanctioned for misprescribing? 4. Have you kept abreast of the latest information on the use of opioids for chronic pain? 5. What are the latest guidelines regarding screening for substance use in patients requesting controlled prescription drugs? 6. Can you identify and manage a patient who misuses controlled substances?
  • 10. CPH© - All Rights Reserved 2011 Introduction If you answered NO for any of these three questions, then this module is for you! We feel it is far better to gain new knowledge than to experience being sanctioned by the medical board. This is the first module within the series. Complete as many modules as you wish or only those most applicable at this time. Revocation Sanction Intervention Prevention
  • 11. CPH© - All Rights Reserved 2011 Instructions Complete the module in order. If you need to return to a section, use the icon to return to the table of contents. This icon is located in the top right hand corner of each page. Click on the title in the table of contents to go directly to that section in the module.
  • 12. CPH© - All Rights Reserved 2011 Table of Contents Table of Contents Importance The CPD Epidemic Misprescribing CPDs Role of the State Medical Board Role of the DEA Summary
  • 13. CPH© - All Rights Reserved 2011 Part 1:
  • 14. CPH© - All Rights Reserved 2011 Importance Did you know that writing one prescription for a controlled substance can cost you a lot of time and money, result in restrictions being placed on your prescribing license, your license to practice medicine, and possibly cost you your career? The sad truth is that it can happen. Many physicians have already lost prescribing privileges, medical licenses, jobs, respect, and careers over misprescribing practices.
  • 15. CPH© - All Rights Reserved 2011 Importance The media will play up the cases of popular individuals who lose their lives due to abuse of controlled prescription drugs (CPD), but what is not always publicized is the story of the everyday physician who lost his/her license to practice because they misprescribed and weren’t even aware of it.
  • 16. CPH© - All Rights Reserved 2011 Importance All healthcare providers who prescribe controlled substances should be well aware that they will be held accountable for their prescribing practices; thus every prescribing physician should follow the published guidelines.
  • 17. CPH© - All Rights Reserved 2011 Importance How familiar are you with the following prescribing guidelines?  The Medical Practice Act  The Controlled Substances Act  Drug Enforcement Administration Practitioner’s Manual  The Federation’s prescribing guidelines  Your state medical board’s prescribing requirements
  • 18. CPH© - All Rights Reserved 2011 Importance Our experience with training hundreds of physicians teaches us that most have had less than 1-2 hours of training on prescribing practices and/or drug diversion during medical school or residency training. How much training did you receive on proper prescribing guidelines? Select only one answer. a) None b) 1-2 hrs c) 3-4 hrs d) >5 hrs
  • 19. CPH© - All Rights Reserved 2011 Part 2:
  • 20. CPH© - All Rights Reserved 2011 The CPD Epidemic Substance abuse, including controlled prescription drugs (CPD), is the nation's number one health problem affecting millions of individuals according to The Robert Wood Johnson Foundation. Illicit drug use, including controlled prescription drugs (pain relievers, stimulants, sedatives, and tranquilizers), marijuana, cocaine, heroin, hallucinogens, and inhalants cost the U.S. economy over $193 billion dollars in 2007; more than either diabetes or smoking alone. (One DCP update vol2;iss5, June 2011)
  • 21. CPH© - All Rights Reserved 2011 The CPD Epidemic "There are more deaths, illnesses and disabilities from substance abuse than from any other preventable health condition. Of the more than 2 million deaths each year in the United States, approximately one in four is attributed to alcohol, tobacco and illicit drug use."
  • 22. CPH© - All Rights Reserved 2011 The CPD Epidemic “According to the 2012 National Survey on Drug Use and Health, almost twice as many Americans (6.8 million) currently abuse pharmaceutical controlled substances than those using cocaine, hallucinogens, heroin and inhalants combined.” “Nearly 110 Americans die every day from drug-related overdoses, and about half of those overdoses are related to opioids, a class of drug that includes prescription painkillers and heroin.”
  • 23. CPH© - All Rights Reserved 2011 The CPD Epidemic “More than two-thirds of people who misuse prescription painkillers for the first time report obtaining the drugs from friends or relatives, including from a home medicine cabinet.” “In July, the Office of National Drug Control Policy (ONDCP) released the 2014 National Drug Control Strategy, which is a “shift away from a law enforcement emphasis and towards a public health and prevention approach to drug-related harm,” according to Davis.”
  • 24. CPH© - All Rights Reserved 2011 The CPD Epidemic “He added that the Strategy emphasizes evidence-based efforts such as increased access to treatment, criminal justice reform and access to naloxone for opioid overdose reversal.” To read more on this report click the RWJ link.
  • 25. CPH© - All Rights Reserved 2011 The CPD Epidemic “Under the Affordable Care Act, most health insurance plans must cover mental health and substance use disorder (SUD) services. The ACA has also created improved access for SUD services by extending a federal law that requires SUD benefits be provided at the same reimbursement rate as medical and surgical benefits.” – RWJ Foundation web page To read more on this report click the RWJ link.
  • 26. CPH© - All Rights Reserved 2011 The CPD Epidemic An estimated 22.6 million Americans (>12 years of age) admitted to using illicit drugs within the past month and this equates to 8.9% for this population and up to 22% for those 18-22 years of age. (SAMSHA) The rate of controlled prescription drug abuse has increased 94% in the past decade (1992 to 2003). Rates have nearly tripled in the teenage population (12 -17 years old) - an increase of 212% compared to 81% increase in the adult population. (Bollinger)
  • 27. CPH© - All Rights Reserved 2011 The CPD Epidemic Rate of controlled prescription drug (CPD) abuse – nearly doubled from 7.8 million to 15.1 million in the past decade (1992 to 2003) • Adults: Use in adults (>18 years) is up by 81% • Teens: Rate has nearly tripled for teen population (age 12 -17): – abusing CPD more than adults – rate estimated at 212%
  • 28. CPH© - All Rights Reserved 2011 The CPD Epidemic In 2010, of the three million new users of illicit drugs for youth aged 12 and older, 62% used marijuana and 26% use CPD. (SAMSHA) Controlled prescription drugs (opioids, stimulants and benzodiazepines) rank number four on the list of most abused substances falling just under marijuana, alcohol and tobacco. (Bollinger)
  • 29. CPH© - All Rights Reserved 2011 The CPD Epidemic Americans make up 4.6% of world’s population but use… – 66% of world’s illicit drugs – 80% of global opioid supply – 99% of global hydrocodone supply 2006 National Survey on Drug Abuse and Health, SAMHSA
  • 30. CPH© - All Rights Reserved 2011 The CPD Epidemic “Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher. In 2008, more than 36,000 people died from drug overdoses, and most of these deaths were caused by prescription drugs.4” • Drug OD from CPD has tripled in two decades (CDC) • 100 people die from OD every day in US (CDC) • Men are more likely to die of opioid overdoses (>10,000 deaths in 2010) (CDC) • Rate of opioid OD for women is increasing (CDC)
  • 31. CPH© - All Rights Reserved 2011 The CPD Epidemic More “new users” tried opioids for non-medical reasons in the past year than any other illicit drug According to the CDC: – Opioid prescription painkillers cause more drug overdose deaths than cocaine and heroin combined – Increased ER visits – Increased accidental deaths – Health care costs = millions of dollars annually DEA Practitioners Manual 2006 ed.; Manchikanti L, et al. 2005; Substance Abuse 2001; Bollinger LC 2005. 2006 National Survey on Drug Abuse and Health, SAMHSA
  • 32. CPH© - All Rights Reserved 2011 The CPD Epidemic The CPD epidemic is real and affects many individuals. The problem with the misuse and illicit use of CPD is the excess burden on the health care system, the individual, family members and the community as a whole. Physicians play two important roles in this problem: 1) Physicians are the main source of CPD. 2) Physicians do not always identify and intervene when misuse and dependence develops.
  • 33. CPH© - All Rights Reserved 2011 The CPD Epidemic Prescription drug diversion is simply the deflection of prescription drugs from medical sources into the illegal market. • Physicians remain the #1 provider of CPD • Other Sources: – doctor shopping – illegal internet pharmacies – drug theft – prescription forgery – illicit prescribing by physicians U.S. Department of Justice, Drug Enforcement Administration, Prescription Accountability Resource Guide, September 1998, <http://www.deadiversion.usdoj.gov/pubs/program/rx_account/index.html > (5 January 2004).
  • 34. CPH© - All Rights Reserved 2011 The CPD Epidemic Source: The Monitoring the Future Study, the University of Michigan Physician misprescribing accounts for most of the excess CPD available for diversion.
  • 35. CPH© - All Rights Reserved 2011 The CPD Epidemic • Up to 43% of physicians DO NOT ask about controlled prescription drug abuse when taking a patient's health history. • Only 19% received any medical school training in identifying prescription drug diversion. • Only 40% received training to identify prescription drug abuse and addiction. • Many are not trained to effectively handle drug- seeking patients Center on Addiction and Substance Abuse (CASA). 2005. Under the Counter: The Diversion and Abuse of Controlled Prescription Drugs in the US. New York: The National Center on Addiction and Substance Abuse (CASA).
  • 36. CPH© - All Rights Reserved 2011 The CPD Epidemic Many are not trained to effectively handle drug-seeking patients due to… “Confrontational Phobia” - a term used to describe physicians’ reluctance to say “no” to a patient, thus making physicians an “easy target for manipulation.” ~ Bollinger et al. Under the Counter: The Diversion and Abuse of Controlled Prescription Drugs in the U.S. July 2005 Center on Addiction and Substance Abuse (CASA). 2005. Under the Counter: The Diversion and Abuse of Controlled Prescription Drugs in the US. New York: The National Center on Addiction and Substance Abuse (CASA).
  • 37. CPH© - All Rights Reserved 2011 Misprescribing CPD Once a physician becomes known as an easy target, substance abusers will find ways to take advantage of them. Here is a comment from a substance abuser: CASA Substance Abuser: “Obviously, doctors don’t like to give you controlled substances easily but if you’re aggressive and persistent enough…and can talk a good enough game, I don’t know how they could not give it to you. I mean they’re in the health field and they’re caring people and they’re trying to take care of their patients’ individual needs.” ~A 52-year-old drug abusing patient interviewed in the CASA study Bollinger et al, 2005
  • 38. CPH© - All Rights Reserved 2011 Misprescribing CPD If the substance abuser knows this much about physicians, what do physicians know about substance abusers? The evidence supports that most physicians weren’t trained to identify and manage substance abuse. Most participants in our courses have never had the training needed to adequately care for the substance abuser or identify those who started using a CPD for legitimate reasons but end up with iatrogenic addictions. Bollinger et al, 2005
  • 39. CPH© - All Rights Reserved 2011 Reflection How much training have you had on identifying and managing substance abuse? a) None b) Some c) A lot d) I don’t know
  • 40. CPH© - All Rights Reserved 2011 Misprescribing CPD
  • 41. CPH© - All Rights Reserved 2011 Misprescribing CPD What is the physician’s role in misprescribing? Am I prescribing for a legitimate medical problem? Am I prescribing the appropriate amount for the condition? Am I giving patients full informed consent? Did I screen appropriately for use vs misuse?
  • 42. CPH© - All Rights Reserved 2011 Misprescribing CPD The majority of excess CPD available for illicit use or sharing is due to physicians or other healthcare providers prescribing more pills than a patient needed. A total of 309 tons of pills were received in the DEA’s 9th Prescription Drug Take-Back Day in November 2014. Other Sources for excess CPD: • doctor shopping • illegal internet pharmacies • drug theft • prescription forgery • illicit prescribing by physicians
  • 43. CPH© - All Rights Reserved 2011 Misprescribing CPD Definition of Misprescribing: Prescribing CPD in quantities and frequency inappropriate for the patient’s complaint or illness … or any example below: Examples: – Prescribing large quantities, frequent intervals, or crescendo pattern of CPD – Progression to multiple drugs – Prescribing CPD painkillers for trivial complaints – Prescribing to a family member(s) – Prescribing to a known alcoholic or drug addict – Dispensing CPD without a license
  • 44. CPH© - All Rights Reserved 2011 Misprescribing CPD Which doctor is at risk of misprescribing? Answer 1 2 3 4
  • 45. CPH© - All Rights Reserved 2011 1.Brown ME, Swiggart WH, Dewey CM, Ghulyan MV. Searching for answers: proper prescribing of controlled prescription drugs. Journal of Psychoactive Drugs. 2012; 44(22641969):79-85. 2.Wesson, D.R. & Smith, D.E. Prescription drug abuse: Patient, physician and cultural responsibilities. Western Journal of Medicine 1990; 152: 613-616. Misprescribing CPD Answer: All physicians who prescribe CPD are at risk of misprescribing if unfamiliar with how to avoid it. There are several reasons why physicians misprescribe. Four identified by the AMA and two later identified by the Center for Professional Health (CPH) (You can read both articles below by clicking the hyper link.) The team at CPH also identified one for advanced nurse practitioners (APRN) and may at times be applicable for physicians as well. Thus physicians misprescribe for the following reasons …
  • 46. CPH© - All Rights Reserved 2011 Misprescribing CPD 1.Brown ME, Swiggart WH, Dewey CM, Ghulyan MV. Searching for answers: proper prescribing of controlled prescription drugs. Journal of Psychoactive Drugs. 2012; 44(22641969):79-85. 2.Wesson, D.R. & Smith, D.E. Prescription drug abuse: Patient, physician and cultural responsibilities. Western Journal of Medicine 1990; 152: 613-616.
  • 47. CPH© - All Rights Reserved 2011 Misprescribing CPD Examples: 1. Dated: A physician is unaware of the latest prescribing guidelines for managing chronic pain and prescribes CPD over the recommended levels. 2. Duped: This is probably the most common reason for misprescribing…the physician fails to detect the deceptive practices of the patient even thought evidence is clearly present. 3. Dismayed: The patient with several problems and complications or side effects to other medications and the physician fails to investigate due to time limitations and the need to move on to the next patient.
  • 48. CPH© - All Rights Reserved 2011 Misprescribing CPD Examples: (cont.) 4. Dysfunctional: This physician feels stressed and unsure of how to handle the forceful patient and fails to say no even when the physician may/may not know the risk involved. 5. Dishonest: This physician, although rare, will exchange CPD for sexual favors or money at street prices for various reasons. 6. Disabled: This physician is also a substance user and may prescribe higher quantities to share with patients or self-prescribes or uses a family name to prescribe CPD but will use it for himself.
  • 49. CPH© - All Rights Reserved 2011 Misprescribing CPD Examples: (cont.) 7. Disempowered: This physician is disempowered by a patient or an APRN is disempowered by a patient or the supervising physician. Either may prescribe because they failed to exhibit the appropriate level of assertiveness within the situation.
  • 50. CPH© - All Rights Reserved 2011 Reflection Reflect on your past prescribing practices. Have you misprescribed? If so, how and for what reason? Categories of Misprescribing Dated: Fails to keep current Disabled: Failed judgment due to impairment Duped: Fails to detect Dishonest: Personal or financial gain Dismayed: Rx as a quick fix due to time Dysfunctional: Fails to say no Disempowered: Skewed perception of power
  • 51. CPH© - All Rights Reserved 2011 Consequences of Misprescribing The consequences for misprescribing can be significant and life/career changing. The consequences can vary greatly from state to state. Both the physician’s medical license and DEA may be restricted or revoked. It is critical that you practice under the guidelines of your state medical board and the federal guidelines of the DEA. Find your state medical board by clicking on the link below.
  • 52. CPH© - All Rights Reserved 2011 Consequences of Misprescribing The physician may be reported to the National Practitioner Data Bank, may lose privileges, be dropped by insurance carriers, and lose respect from patients and colleagues. When misprescribing crosses the legal lines of justice, a physician may be arrested.
  • 53. CPH© - All Rights Reserved 2011 Consequences of Misprescribing The financial and personal toll of being sanctioned for misprescribing is significant. Direct and indirect costs include: • Loss of income • Loss of privileges • Loss of respect • Costs for educational programs • Cost for lawyer fees • Cost for board fees • Cost for addiction assessments & treatment
  • 54. CPH© - All Rights Reserved 2011 Part 3:
  • 55. CPH© - All Rights Reserved 2011 State Medical Board Under the Modern Medical Practice Act, the “state medical board, acting as a governmental agency, to regulate the practice of medicine, including the licensure and discipline of physicians, in the jurisdiction.” Each state’s Act varies in how they award or revoke licenses. In TN, the state board’s mission is to “safeguard the health, safety, and welfare” of the public and interpret the laws, rules, and regulations to determine the “appropriate standards of practice to ensure the highest degree of professional conduct.” (TN SBME)
  • 56. CPH© - All Rights Reserved 2011 State Medical Board Within each state’s regulations, the board will investigate all complaints of alleged violations. The board will hold physicians accountable for their competency and behavior and will strike a balance between enforcing accountability and being punitive – meaning they will discipline licensees who are found guilty of violations based on evidence from an investigation.
  • 57. CPH© - All Rights Reserved 2011 State Medical Board In most instances, the board will render a judgment based on behavior, not only on patient outcomes, and will try to distinguish between human error and intentional reckless behavior. The board may require education, coaching, non- disciplinary counseling, training, and request evidence of competency if appropriate.
  • 58. CPH© - All Rights Reserved 2011 State Medical Board The medical board considers disciplinary/punitive action for any event/medical error resulting from a practitioner under the influence (ETOH or drugs), recklessly unsafe practitioners, and any practitioner who has blatantly disregarded the standards of practice or has committed a criminal act. The medical board will not randomly select physicians to survey or investigate. All inquiries are complaint driven. When the board receives a complaint, they will investigate to determine if there is evidence of a possible violation.
  • 59. CPH© - All Rights Reserved 2011 State Medical Board The board’s course of action generally includes: 1) assign an investigator to make an inquiry 2) send a “notice of complaint” to the doctor where an explanation may be requested 3) the investigator will either schedule a meeting with the physician or randomly visit the physician
  • 60. CPH© - All Rights Reserved 2011 State Medical Board Board investigators will request records to review. The board will expect that the physician records the following for each patient receiving CPD: 1. proper indication for the use of the CPD 2. plans for monitoring the patient while on the CPD 3. the response to using a CPD on follow-up visits 4. a rationale for continuing or modifying therapy. If there is a clear concern for public safety, the board may take an immediate action and suspend the doctor’s license.
  • 61. CPH© - All Rights Reserved 2011 State Medical Board Most complaints are resolved as follows: 1) Dismissal - lack of evidence to support the claim 2) Letter of Concern - a letter from the board is generated expressing concern regarding an action 3) Consent Decree - an agreement is used for concerns such as an expired license or incomplete CME requirements 4) Agreed Order – a formal disciplinary action in which both sides agree that the complaint is valid and the doctor agrees to certain terms and/or conditions.
  • 62. CPH© - All Rights Reserved 2011 State Medical Board List of actions a board can take: 1. Revocation of the medical license 2. Suspension of the medical license 3. Probation 4. Stipulations, limitations, restrictions, probation, and conditions relating to practice 5. Censure (including specific redress, if appropriate) 6. Reprimand 7. Chastisement, letters of concern and advisory letters
  • 63. CPH© - All Rights Reserved 2011 State Medical Board 8. Monetary redress to another party 9. A period of free public or charity service, either medical or non- medical 10.Satisfactory completion of an educational, training and/or treatment program(s), or professional developmental plan 11.Levy fine 12.Payment of administrative and disciplinary costs
  • 64. CPH© - All Rights Reserved 2011 State Medical Board If appropriate, the board will proceed with a Hearing - a formal trial-like procedure where the case is presented to the medical board panel. In this process, the physician will take part in a pre-hearing conference (a conference between the doctor and the investigator including attorneys to discuss the case) followed by the hearing. The board will vote on any decisions in open session and determine a proposed decision. The decision can be appealed to the Circuit Court within 30 days.
  • 65. CPH© - All Rights Reserved 2011 State Medical Board National Practitioners Data Bank: Final actions are reported to the Data Bank newsletter and web site. All costs plus penalties are assessed to the physician and can be excessive especially if the physician retains a lawyer on his/her behalf.
  • 66. CPH© - All Rights Reserved 2011 State Medical Board If a physician receives notice from their board of a complaint, they should consider seeking guidance from their state’s physician health program (PHP). Most states have a PHP and can provide insight into the process and make suggestions on compliance and training options. Some will suggest proactive assessments, training and education. Common PHP and board suggestions/requirements include training courses for improving documentation and proper prescribing such as the CME courses at CPH.
  • 67. CPH© - All Rights Reserved 2011 Part 4:
  • 68. CPH© - All Rights Reserved 2011 Drug Enforcement Administration The mission of the DEA is to enforce the controlled substances laws and regulations of the United States and to recommend and support non-enforcement programs aimed at reducing the availability of illicit controlled substances. The DEA was created by President Richard Nixon through an Executive Order in July 1973 in order to establish a single unified command to combat "an all-out global war on the drug menace." Through the Controlled Substances Act (CSA) of 1970, he assigned legal authority for the regulation of controlled substances (illicit and licit).
  • 69. CPH© - All Rights Reserved 2011 Controlled Substances Act (CSA) – Monitors: 1. Diversion to illicit use in: – Self – Others 2. Maintenance of addictions 3. Iatrogenic addictions – Defined five (5) schedules – All prescribers must be registered
  • 70. CPH© - All Rights Reserved 2011 DEA The DEA has two major responsibilities: 1. Diversion: The prevention, detection, and investigation of the diversion of controlled substances from legitimate channels 2. Adequate Supplies: Ensuring that adequate supplies are available to meet legitimate domestic medical, scientific, and industrial needs (production to dispensing)
  • 71. CPH© - All Rights Reserved 2011 DEA DEA registration can be suspended or revoked by the Attorney General upon a finding that the registrant: – Falsified an application – Has been convicted of a felony – Had state license/registration suspended, revoked, or denied by competent State authority – Has committed acts that would render registration inconsistent with the public interest – Has been excluded (or directed to be excluded) from participation in a program pursuant to section 1320a-7(a) of title 42. (improperly filed claims) – this is essentially Medicare fraud.
  • 72. CPH© - All Rights Reserved 2011 DEA The DEA developed and published the Practitioner’s Manual: An Informational Outline of the Controlled Substances Act 2006 Edition. It is available on their web page. The manual provides an overview and practice guidelines for physicians, physician assistants, advanced nurse practitioners, and pharmacists. The DEA remains committed to the 2001 Balanced Policy of promoting pain relief & preventing abuse of pain medications. If you have not read the manual, this is a must read for those prescribing controlled substances.
  • 73. CPH© - All Rights Reserved 2011 DEA - Questions 1. What constitutes Schedule I or other schedule assignments for drugs? 2. Identify the schedule for each of the following: marijuana; morphine; heroin; codeine; LSD; opium; amphetamine; cocaine 3. How often do you renew your DEA registration and what happens if you move? 4. Which schedules can be refilled? 5. Can Schedule II prescriptions be faxed? 6. What do the numbers and letters in a DEA number stand for? How is it different from the NPI number? 7. Can you “detox” a controlled substance user (using methadone) under your current DEA registration? DEA Practitioner’s Manual 2006; pg. 5-6 & 9-11 & 21-22 & 23
  • 74. CPH© - All Rights Reserved 2011 DEA If you are unsure of any of the answers to the above questions, please continue reading module 2: The Proper Prescribing of Controlled Prescription Drugs. Module 2 combines the guidelines from the Practitioner’s Manual with a reasonable approach to prescribing practices based on the standard office practices using the SOAP format.
  • 75. CPH© - All Rights Reserved 2011 Summary Having completed this module you should be able to: 1. Discuss the CPD epidemic. 2. Define misprescribing of CPD. 3. Compare and contrast the role of the medical board and the DEA. 4. Identified your own risk for misprescribing. So the question remains, “Are you at risk for misprescribing?” Continue learning in Module 2 to determine other risks for misprescribing and some tips to avoid misprescribing.
  • 76. CPH© - All Rights Reserved 2011 The Center for Professional Health Contact us at: Center for Professional Health 1107 Oxford House Vanderbilt University Medical Center Nashville, TN. 37232-4300 (615) 936-0678 (phone) (615) 936-0676 (fax) cph@vanderbilt.edu

Editor's Notes

  1. http://www.mc.vanderbilt.edu/root/vumc.php?site=cph
  2. https://www.bing.com/images/search?q=free%20clip%20art%20thinking&qs=n&form=QBIR&pq=free%20clip%20art%20thinking&sc=5-21&sp=-1&sk=
  3. RWJ Foundation at: http://www.rwjf.org/en/blogs/new-public-health/2014/10/drug_abuse_controlg.html – Accessed 1/9/2015 (One DCP update vol2;iss5, June 2011)
  4. http://www.rwjf.org/en/research-publications/find-rwjf-research/2012/01/substance-abuse-policy-research-program.html Problem Synopsis: According to a 2001 report from researchers at Brandeis University,
  5. http://www.rwjf.org/en/blogs/new-public-health/2014/10/drug_abuse_controlg.html
  6. http://www.rwjf.org/en/blogs/new-public-health/2014/10/drug_abuse_controlg.html
  7. http://www.rwjf.org/en/blogs/new-public-health/2014/10/drug_abuse_controlg.html
  8. http://www.rwjf.org/en/blogs/new-public-health/2014/10/drug_abuse_controlg.html
  9. Last accessed 1/9/2015 SAMHSA at http://www.samhsa.gov/ Bollinger 2005 article: http://www.casacolumbia.org/addiction-research/reports/under-the-counter-diversion-abuse-controlled-perscription-drugs CASA at http://www.casacolumbia.org/ Manchikanti 2007 Article: http://www.cfbhn.org/Documents/RX/National%20Drug%20Control%20Policy%20and%20Prescription%20Drug%20Abuse%20Facts%20and%20Fallacies.pdf
  10. 2011
  11. 2011
  12. Men vs women opioid OD: http://www.cdc.gov/vitalsigns/PrescriptionPainkillerOverdoses/ http://www.cdc.gov/homeandrecreationalsafety/rxbrief/
  13. 2011
  14. 2011
  15. 2011
  16. Add audio describing the table – physician misprescribing makes up most of excess CPD
  17. 2011
  18. Center on Addiction and Substance Abuse (CASA). 2005. Under the Counter: The Diversion and Abuse of Controlled Prescription Drugs in the US. New York: The National Center on Addiction and Substance Abuse (CASA). http://www.casacolumbia.org/addiction-research/reports/under-the-counter-diversion-abuse-controlled-perscription-drugs
  19. http://www.casacolumbia.org/addiction-research/reports/under-the-counter-diversion-abuse-controlled-perscription-drugs
  20. http://www.casacolumbia.org/addiction-research/reports/under-the-counter-diversion-abuse-controlled-perscription-drugs
  21. U.S. Department of Justice, Drug Enforcement Administration, Prescription Accountability Resource Guide, September 1998, <http://www.deadiversion.usdoj.gov/pubs/program/rx_account/index.html > (5 January 2004). 9th annual CPD take back day 2014 – last accessed 1/9/2015: http://www.dea.gov/divisions/hq/2014/hq110514.shtml
  22. 1. Brown ME, Swiggart WH, Dewey CM, Ghulyan MV. Searching for answers: proper prescribing of controlled prescription drugs. Journal of Psychoactive Drugs. 2012; 44(22641969):79-85. 2. Wesson, D.R. & Smith, D.E. Prescription drug abuse: Patient, physician and cultural responsibilities. Western Journal of Medicine 1990; 152: 613-616.
  23. 1. Brown ME, Swiggart WH, Dewey CM, Ghulyan MV. Searching for answers: proper prescribing of controlled prescription drugs. Journal of Psychoactive Drugs. 2012; 44(22641969):79-85. 2. Wesson, D.R. & Smith, D.E. Prescription drug abuse: Patient, physician and cultural responsibilities. Western Journal of Medicine 1990; 152: 613-616.
  24. http://www.fsmb.org/ http://www.dea.gov/index.shtml
  25. FSMB Modern Medical Practice act guide: http://library.fsmb.org/centennial/pdf/essentials-1970.pdf and the osteopathic 2012 version at: http://library.fsmb.org/pdf/GRPOL_essentials.pdf https://health.state.tn.us/boards/Me/
  26. http://www.fsmb.org/Media/Default/PDF/FSMB/Advocacy/GRPOL_essentials.pdf
  27. 2011
  28. 2011
  29. 2011
  30. 2011
  31. 2011
  32. 2011
  33. https://www.bing.com/images/search?q=pills&go=Submit&qs=n&form=QBIR&pq=pills&sc=8-3&sp=-1&sk=#view=detail&id=8F5FEB782B920D16C5FFB021A49ACA503E2BAD15&selectedIndex=27